G. Said
Orphanet Journal of Rare Diseases · 2007–2013
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.
Whom G. Said trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts G. Said overall
Papers from G. Said's perspective
Ordered by how strongly the researchers G. Said trusts endorse each paper. Same corpus, a different order for every researcher.
- Systemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main Types (Circulation)
- The Metabolic and Molecular Bases of Inherited Disease
- Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. (European Heart Journal)
- Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. (Journal of the American College of Cardiology)
- Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (New England Journal of Medicine)
- Autophagy in metazoans: cell survival in the land of plenty (Nature reviews. Molecular cell biology)
- Selective versus total insulin resistance: a pathogenic paradox. (Cell Metabolism)
- A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 (Nature Genetics)
- Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. (Journal of Clinical Investigation)
- Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. (Annual Review of Immunology)
Their papers
- Guideline of transthyretin-related hereditary amyloidosis for clinicians (2013) — 662 citations
- Diabetic neuropathy—a review (2007) — 635 citations